MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04913cam a2200589 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn923009432 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221128212946.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
150425s2015 nyu ob 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2020688007 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| 019 ## - |
|---|
| -- |
947129237 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9781634829175 |
| Qualifying information |
ebook |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
1634829174 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781634829052 |
| Qualifying information |
hbk. |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
1634829050 |
| Qualifying information |
hbk. |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
1078033 |
| -- |
(N$T) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)923009432 |
| Canceled/invalid control number |
(OCoLC)947129237 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
HEA |
| Subject category code subdivision |
039000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
014000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
022000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
112000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
045000 |
| Source |
bisacsh |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Myotonic dystrophies : |
| Subtitle |
epidemiology, diagnosis and therapeutic challenges |
| Statement of responsibility, etc |
|
| Medium |
[E-Book] |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Nova Biomedical, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2015] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
1 online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 490 1# - SERIES TITLE |
|---|
| Series statement |
Neuroscience research progress |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - CONTENTS |
|---|
| Contents |
MYOTONIC DYSTROPHIES EPIDEMIOLOGY, DIAGNOSIS AND THERAPEUTIC CHALLENGES ; MYOTONIC DYSTROPHIES EPIDEMIOLOGY, DIAGNOSIS AND THERAPEUTIC CHALLENGES ; Contents ; Preface ; Chapter 1 Epidemiology of Myotonic Dystrophy in the Molecular Era: Implications for Clinical Trials and Association Studies ; Abstract ; Introduction ; The Population Origins of DM1 ; The Epidemiology of DM1 ; The Epidemiology of DM2 ; Implications for Clinical Trials and Association Studies ; Conclusion ; References ; Chapter 2 Detecting and Targeting RNA: Biomarkers and Therapy for Myotonic Dystrophy ; Abstract |
| 505 8# - CONTENTS |
|---|
| Contents |
Introduction Development of Biomarkers for Myotonic Dystrophy Type 1 (DM1) ; Blood-based Biomarkers ; Tissue Biomarkers ; Cerebrospinal Fluid Biomarkers ; Potential Therapeutic Applications for DM1 ; Targeting the Pathogenic DM1 RNA Transcripts ; Exogenous Induction of MBNL1 and CUGBP1 Protein Activity ; Conclusion; References; Chapter 3 Endocrine System Involvement in Myotonic Dystrophy: Emerging Interactions and Potential Therapeutic Strategies ; Abstract; Introduction ; Parathyroid and Thyroid-Related Hormones ; Vitamin D ; Insulin Resistance and Metabolic Syndrome |
| 505 8# - CONTENTS |
|---|
| Contents |
Adrenocortical Activity Hypogonadism and Fertility ; Conclusion ; References ; Chapter 4 Central Nervous System Involvement in Myotonic Dystrophies ; Abstract ; Introduction ; Cognitive Impairment in Myotonic Dystrophy Type 1 (DM1, Steinert's Disease) ; Cognitive Involvement in DM2 ; Sleep Related Disorders in DM1 and DM2 ; Conclusion ; References ; Chapter 5 Strategies for Neuromuscular Blockade in Patients with Myotonic Dystrophy ; Abstract ; The Physiology of Neuromuscular Transmission ; Myotonic Pathophysiology from an Anaesthesiology Viewpoint ; Premedication |
| 505 8# - CONTENTS |
|---|
| Contents |
Induction of Anaesthesia Response to Muscle Relaxants ; Reverse of Neuromuscular Blockade ; Other Perioperative Triggers ; Management of Anaesthesia in Patients with Myotonic Dystrophy; Caesarean Section ; Scoliosis Surgery ; General Surgery ; Conclusion ; Acknowledgment ; Reference; Chapter 6 Functional Assessment and Rehabilitative Treatment in Myotonic Dystrophy Type 1 ; Abstract ; Introduction; 1. Functional Assessment ; 1.1. Muscle Strength; 1.2. Posture and Gait Abilities ; Clinical Evaluation: Muscle Efficiency ; Rehabilitative Treatment ; References |
| 505 8# - CONTENTS |
|---|
| Contents |
Chapter 7 Protein Kinase Inhibitors As Potential Therapeutic Agents to Ameliorate Pathogenesis of Myotonic Dystrophy Type 1 (DM1) Abstract ; Introduction; Toxicity of Mutant CUG Repeat RNA and Misregulation of Proteins in DM1 ; Therapeutic Approaches in DM1 ; Potential Mechanisms of Action of Small Molecule Kinase Inhibitors ; Conclusion ; Acknowledgments ; References ; Chapter 8 Variant Interrupted DMPK Alleles: Implications in the Pathogenesis and Molecular Diagnosis of Myotonic Dystrophy Type 1 (DM1) ; Abstract; Molecular Genetics of the DM1 Mutation |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
Master record variable field(s) change: 050, 082 |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Myotonia atrophica |
| General subdivision |
Treatment. |
| 650 #2 - SUBJECT HEADINGS |
|---|
| Subject term |
Myotonic Dystrophy |
| General subdivision |
therapy. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Jenkins, Sandra |
| Titles and other words associated with a name |
(Writer on Myotonic dystrophies), |
| Relator term |
editor. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Neuroscience research progress. |
| 856 40 - ONLINE RESOURCE |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1078033">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1078033</a> |
| Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
Do not Suppress in OPAC |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Description based on print version record. |
| 938 ## - |
|---|
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL4189164 |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
12428456 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
1078033 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
N$T |